Market Research Logo

Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2018

Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2018 provides an overview of Individual and Specified Hormones currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Individual and Specified Hormones pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Individual and Specified Hormones under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Individual and Specified Hormones and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Individual and Specified Hormones under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Individual and Specified Hormones Overview
3 Products under Development
3.1 Individual and Specified Hormones - Pipeline Products by Stage of Development
3.2 Individual and Specified Hormones - Pipeline Products by Segment
3.3 Individual and Specified Hormones - Pipeline Products by Territory
3.4 Individual and Specified Hormones - Pipeline Products by Regulatory Path
3.5 Individual and Specified Hormones - Pipeline Products by Estimated Approval Date
4 Individual and Specified Hormones - Pipeline Products under Development by Companies
4.1 Individual and Specified Hormones Companies - Pipeline Products by Stage of Development
4.2 Individual and Specified Hormones - Pipeline Products by Stage of Development
5 Individual and Specified Hormones Companies and Product Overview
5.1 Alere Inc Company Overview
5.2 AMS Diagnostics LLC Company Overview
5.3 Beckman Coulter Inc Company Overview
5.4 Carolina Liquid Chemistries Corp Company Overview
5.5 Ceres Nanosciences Inc Company Overview
5.6 Columbia University Company Overview
5.7 DiaSorin SpA Company Overview
5.8 DIAsource ImmunoAssays SA Company Overview
5.9 Fujirebio Diagnostics Inc Company Overview
5.10 Immunodiagnostic Systems Holdings plc Company Overview
5.11 Mindray Medical International Ltd Company Overview
5.12 Novartis AG Company Overview
5.13 OJ-Bio Ltd Company Overview
5.14 Roche Diagnostics International Ltd Company Overview
5.15 Sendera Discovery Company Overview
5.16 Siemens Healthcare GmbH Company Overview
5.17 Thermo Fisher Scientific Inc Company Overview
5.18 Tosoh Bioscience Inc Company Overview
6 Individual and Specified Hormones- Recent Developments
6.1 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018
6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers
6.3 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics
6.4 May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018
6.5 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future
6.6 May 07, 2018: Luminex Announces First Quarter 2018 Financial Results
6.7 May 03, 2018: Siemens Healthineers fully on track to meet the targets
6.8 Apr 23, 2018: Science Start-Ups Gain Strong Momentum at the Prince William Science Accelerator
6.9 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results
6.10 Mar 26, 2018: New Study Highlights the Use of MR-proADM in Assessing Disease Severity and Treatment Response in Patients with Sepsis and Septic Shock
6.11 Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018
6.12 Feb 12, 2018: Luminex Reports Fourth Quarter and Full-Year 2017 Financial Results
6.13 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics
6.14 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results
6.15 Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers
6.16 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange
6.17 Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017
6.18 Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed
6.19 Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change
6.20 Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results
6.21 Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017
6.22 Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results
6.23 Sep 22, 2017: Abbott and the Abbott Fund Provide $2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico
6.24 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With $1 Million to Help Families Affected by Hurricane Irma
6.25 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index
6.26 Aug 29, 2017: Abbott and the Abbott Fund Donate $1 Million to Support Hurricane Harvey Relief Efforts
6.27 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results
6.28 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017
6.29 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Individual and Specified Hormones - Pipeline Products by Stage of Development
Table 2: Individual and Specified Hormones - Pipeline Products by Segment
Table 3: Individual and Specified Hormones - Pipeline Products by Territory
Table 4: Individual and Specified Hormones - Pipeline Products by Regulatory Path
Table 5: Individual and Specified Hormones - Pipeline Products by Estimated Approval Date
Table 6: Individual and Specified Hormones Companies - Pipeline Products by Stage of Development
Table 7: Individual and Specified Hormones - Pipeline Products by Stage of Development
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Vitamin D Assay - Product Status
Table 10: Vitamin D Assay - Product Description
Table 11: AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 12: LIASYS 330 - Vitamin D Assay - Product Status
Table 13: LIASYS 330 - Vitamin D Assay - Product Description
Table 14: Liasys 450 - Vitamin D Assay - Product Status
Table 15: Liasys 450 - Vitamin D Assay - Product Description
Table 16: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay - Product Status
Table 18: UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay - Product Description
Table 19: Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 20: CLC 480 Analyzer - Vitamin D Assay - Product Status
Table 21: CLC 480 Analyzer - Vitamin D Assay - Product Description
Table 22: CLC 720i Analyzer - Vitamin D Assay - Product Status
Table 23: CLC 720i Analyzer - Vitamin D Assay - Product Description
Table 24: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Nanotrap Human Growth Hormone Test - Product Status
Table 26: Nanotrap Human Growth Hormone Test - Product Description
Table 27: Columbia University Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Diagnostic Test - Menopause - Product Status
Table 29: Diagnostic Test - Menopause - Product Description
Table 30: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview
Table 31: LIAISON - High Sclerostin Assay - Product Status
Table 32: LIAISON - High Sclerostin Assay - Product Description
Table 33: LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Status
Table 34: LIAISON - Hyperphosphate Low Bone Turnover Assay - Product Description
Table 35: LIAISON XL - Sclerostin Assay - Product Status
Table 36: LIAISON XL - Sclerostin Assay - Product Description
Table 37: DIAsource ImmunoAssays SA Pipeline Products & Ongoing Clinical Trials Overview
Table 38: 25-OH Vitamin D Total ELISA Test - Product Status
Table 39: 25-OH Vitamin D Total ELISA Test - Product Description
Table 40: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Lumipulse G1200 - Whole PTH - Product Status
Table 42: Lumipulse G1200 - Whole PTH - Product Description
Table 43: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: IDS-iSYS Cortisol Assay - Product Status
Table 45: IDS-iSYS Cortisol Assay - Product Description
Table 46: IDS-iSYS Intact PINP Assay - Product Status
Table 47: IDS-iSYS Intact PINP Assay - Product Description
Table 48: IDS-iSYS MGP Assay - Product Status
Table 49: IDS-iSYS MGP Assay - Product Description
Table 50: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 51: CL-1000i - Calcitonin Test - Product Status
Table 52: CL-1000i - Calcitonin Test - Product Description
Table 53: CL-1000i - Intact PTH Test - Product Status
Table 54: CL-1000i - Intact PTH Test - Product Description
Table 55: CL-1000i - Vitamin D Total Test - Product Status
Table 56: CL-1000i - Vitamin D Total Test - Product Description
Table 57: CL-2000i - ACTH Test - Product Status
Table 58: CL-2000i - ACTH Test - Product Description
Table 59: CL-2000i - Calcitonin Test - Product Status
Table 60: CL-2000i - Calcitonin Test - Product Description
Table 61: CL-2000i - Cortisol Test - Product Status
Table 62: CL-2000i - Cortisol Test - Product Description
Table 63: CL-2000i - PTH Test - Product Status
Table 64: CL-2000i - PTH Test - Product Description
Table 65: CL-2000i - Vitamin D Total Test - Product Status
Table 66: CL-2000i - Vitamin D Total Test - Product Description
Table 67: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Rapid Diagnostic Test - Vitamin D - Product Status
Table 69: Rapid Diagnostic Test - Vitamin D - Product Description
Table 70: OJ-Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Parathyroid Hormone Assay - Product Status
Table 72: Parathyroid Hormone Assay - Product Description
Table 73: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: Cobas 4000 Analyzer Series With e 411 Module - IGF-1 Assay - Product Status
Table 75: Cobas 4000 Analyzer Series With e 411 Module - IGF-1 Assay - Product Description
Table 76: Cobas 6000 Analyzer Series With c 501 Module - IGF BP3 Assay - Product Status
Table 77: Cobas 6000 Analyzer Series With c 501 Module - IGF BP3 Assay - Product Description
Table 78: Cobas 6000 Analyzer Series With c 501 Module - IGF-1 Assay - Product Status
Table 79: Cobas 6000 Analyzer Series With c 501 Module - IGF-1 Assay - Product Description
Table 80: Cobas 6000 Analyzer Series With e 601 Module - IGF BP3 Assay - Product Status
Table 81: Cobas 6000 Analyzer Series With e 601 Module - IGF BP3 Assay - Product Description
Table 82: Cobas 6000 Analyzer Series With e 601 Module - IGF-1 Assay - Product Status
Table 83: Cobas 6000 Analyzer Series With e 601 Module - IGF-1 Assay - Product Description
Table 84: Cobas 8000 Analyzer Series With c 502 Module - IGF BP3 Assay - Product Status
Table 85: Cobas 8000 Analyzer Series With c 502 Module - IGF BP3 Assay - Product Description
Table 86: Cobas 8000 Analyzer Series With c 502 Module - IGF-1 Assay - Product Status
Table 87: Cobas 8000 Analyzer Series With c 502 Module - IGF-1 Assay - Product Description
Table 88: Cobas 8000 Analyzer Series With c 701 Module - IGF BP3 Assay - Product Status
Table 89: Cobas 8000 Analyzer Series With c 701 Module - IGF BP3 Assay - Product Description
Table 90: Cobas 8000 Analyzer Series With c 701 Module - IGF-1 - Product Status
Table 91: Cobas 8000 Analyzer Series With c 701 Module - IGF-1 - Product Description
Table 92: Cobas 8000 Analyzer Series With c 702 Module - IGF-1 Assay - Product Status
Table 93: Cobas 8000 Analyzer Series With c 702 Module - IGF-1 Assay - Product Description
Table 94: Cobas 8000 Analyzer Series With e 602 Module - IGF BP3 Assay - Product Status
Table 95: Cobas 8000 Analyzer Series With e 602 Module - IGF BP3 Assay - Product Description
Table 96: Cobas 8000 Analyzer Series With e 602 Module - IGF-1 Assay - Product Status
Table 97: Cobas 8000 Analyzer Series With e 602 Module - IGF-1 Assay - Product Description
Table 98: Cobas 8000 Analyzer Series With e 801 Module - IGF BP3 Assay - Product Status
Table 99: Cobas 8000 Analyzer Series With e 801 Module - IGF BP3 Assay - Product Description
Table 100: Cobas 8000 Analyzer Series With e 801 Module - IGF-1 Assay - Product Status
Table 101: Cobas 8000 Analyzer Series With e 801 Module - IGF-1 Assay - Product Description
Table 102: Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview
Table 103: In-Vitro Diagnostic Kit - Androgen Replacement Therapy - Product Status
Table 104: In-Vitro Diagnostic Kit - Androgen Replacement Therapy - Product Description
Table 105: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 106: ADVIA Centaur CP Immunoassay System - Vitamin D Assay - Product Status
Table 107: ADVIA Centaur CP Immunoassay System - Vitamin D Assay - Product Description
Table 108: Dimension EXL 200 Integrated Chemistry System - LOCI IPTH - Product Status
Table 109: Dimension EXL 200 Integrated Chemistry System - LOCI IPTH - Product Description
Table 110: Dimension EXL 200 Integrated Chemistry System - Vitamin D Assay - Product Status
1.2 List of Figures
Figure 1: Individual and Specified Hormones - Pipeline Products by Stage of Development
Figure 2: Individual and Specified Hormones - Pipeline Products by Segment
Figure 3: Individual and Specified Hormones - Pipeline Products by Territory
Figure 4: Individual and Specified Hormones - Pipeline Products by Regulatory Path
Figure 5: Individual and Specified Hormones - Pipeline Products by Estimated Approval Date

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report